Kefir powder tested as Weight-Loss aid for kids

NCT ID NCT06500104

ENROLLING_BY_INVITATION Disease control Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily kefir peptide supplement can help obese children lose weight and improve related health issues like insulin resistance and fatty liver. Sixty children with a BMI above the 95th percentile will take either kefir or a placebo for 12 weeks. The goal is to see if this traditional fermented dairy product can offer a simple, safe way to manage childhood obesity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: kefir peptide (dietary supplement)
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage obesity and related conditions like insulin resistance and fatty liver in children.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply broadly. The supplement is not a cure and may have limited effect on weight loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

China Medical University Children's Hospital

Taichung, 404, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.